Clinical Trials · NCT05073835
Semaglutide 2.4 mg in Patients With Poor Weight-loss
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- University College, London
- Enrollment
- 70
- Start date
- Nov 2022
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Weight loss